US Stocks
/
Milestone Pharmaceuticals Inc. Share Price

Milestone Pharmaceuticals Inc. Share Price

NASDAQ: MIST | Micro Cap
$1.16
-$0.03 (-2.52%) Last updated on 29 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Milestone Pharmaceuticals Inc. Stock Performance

Open
$1.18
Prev. Close
$1.19
Circuit Range
N/A
Day Range
$1.14 - $1.18
Year Range
$1.00 - $3.05
Volume
30,988
Average Traded
$1.15

Milestone Pharmaceuticals Inc. Share Price Today

As of 29 August 2026, Milestone Pharmaceuticals Inc.'s share price is $1.16. The stock opened at $1.18, compared to its previous close of $1.19. During today's trading session, Milestone Pharmaceuticals Inc.'s share price traded between $1.14 and $1.18, with an average price of $1.16. Over the past 52 weeks, the stock has recorded a high of $3.05 and a low of $1.00. In terms of performance, Milestone Pharmaceuticals Inc.'s share price has declined by 32.36% over the last six months and is down 36.61% on a year-on-year basis.

Milestone Pharmaceuticals Inc. Share Price Chart

$1.14$1.18
L
Show Current Price
H

Milestone Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Market Cap
$97.53M
PE Ratio (TTM)
-1.55
Dividend Yield
N/A
EPS (TTM)
$-0.75
Revenue (TTM)
$1.55M
Return On Equity (TTM)
-150.97%
Profit Margin
-4078.78%
Debt to Equity
1.72
Quarterly Earnings Growth YoY
-26.31%

Milestone Pharmaceuticals Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/A$0.00$0.00$0.00$0.00$0.00
Net Profit-$10.35M-$9.36M-$9.44M-$20.76M-$12.97M-$11.92M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A9.57%-0.81%-119.95%37.55%8.05%

Milestone Pharmaceuticals Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$1.55M
Net Profit-$41.52M-$63.06M
Net Profit MarginN/A-4078.78%
Income ChangeN/A-51.88%

About Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.

Milestone Pharmaceuticals Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$1.08
$1.19
+7.69%
Jul 2026
$1.35
$1.10
-17.54%
Jun 2026
$1.39
$1.34
-5.96%
May 2026
$1.79
$1.43
-20.83%
Apr 2026
$1.24
$1.80
+50.00%
Mar 2026
$1.69
$1.20
-30.03%
Feb 2026
$1.93
$1.72
-10.68%
Jan 2026
$2.05
$1.92
-5.19%
Dec 2025
$2.68
$2.02
-24.30%
Nov 2025
$1.95
$2.67
+38.96%
Oct 2025
$2.00
$1.93
-4.18%
Sep 2025
$1.87
$2.01
+9.78%

MIST Share Price FAQs

What is Milestone Pharmaceuticals Inc. share price today?

chevron-up
Milestone Pharmaceuticals Inc. share price today is $1.16 as on August 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Milestone Pharmaceuticals Inc. stock?

chevron-up
The 52 week high of Milestone Pharmaceuticals Inc. stock is $3.05, while the 52 week low is $1.00 as of 29 Aug '26.

What is MIST's market capitalisation today?

chevron-up
MIST market capitalisation is $97.53M as of August 29, 2026, at 10:21 pm IST.

What is MIST's net income for the last quarter?

chevron-up
MIST's net income for the last quarter is -0.01B USD.

What is the 5 year returns of MIST?

chevron-up
The 5 year returns of MIST is -80.89% as on 29 Aug '26.

What is the high & low stock price of MIST today?

chevron-up
MIST stock price hit a high of $1.18 and low of $1.14 as of 29 Aug '26.

Can I buy MIST shares in India?

chevron-up
Yes. You can buy MIST in India by opening an international trading account.